BackViracta Therapeutics Overview
Viracta Therapeutics Inc

Viracta Therapeutics Target Price

Analysts' 12-month price predictions for VIRX.

Get informed when a big investor buys or sells

+ Follow

Share Price

$0.01

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2022-11-11RBC Capital$881532.7% upsideOpen